Geriatric nephrology and urology最新文献

Peer-to-peer connections: Perceptions of a social support app designed for young adults with cancer. 同伴之间的联系：对专为年轻癌症患者设计的社交支持应用程序的看法。

IF 3.3

Geriatric nephrology and urology Pub Date : 2020-01-01 Epub Date: 2019-09-16 DOI: 10.1002/pon.5220

Allison J Lazard, Adam J Saffer, Lindsey Horrell, Catherine Benedict, Brad Love

{"title":"Peer-to-peer connections: Perceptions of a social support app designed for young adults with cancer.","authors":"Allison J Lazard, Adam J Saffer, Lindsey Horrell, Catherine Benedict, Brad Love","doi":"10.1002/pon.5220","DOIUrl":"10.1002/pon.5220","url":null,"abstract":"Objective: Social support is a critical, yet frequently unmet, need among young adults (YAs) with cancer. YAs desire age-appropriate resources to connect with peers. Peer-to-peer mobile apps are promising interventions to provide social support. Peer-to-peer apps will be more effective if development incorporates users' input for whether app designs (look and function) afford meaningful connections.Methods: We interviewed 22 YAs to assess perceptions of a peer-to-peer app at a YA cancer convention in April 2017.Results: Participants were an average age of 29, mostly female (77%), white (73%), and well educated (68% with 4-year college degree or higher). Most participants expressed interested in using an app to connect with YAs, but preferences varied by prevalence or rarity of one's cancer diagnosis. YAs shared trade-offs for profile anonymity versus profiles with more personal information, requests for filter options to connect for varying support needs, and desires for tailored messaging and chat room features (eg, topic-specific and search capabilities).Conclusion: Findings demonstrate the promise of apps to fulfill YA cancer survivors' unmet peer support needs and provide guidance for app optimization.Clinical implications: Peer-to-peer support apps should be designed so users can control their identity and customize features for meaningful connections.","PeriodicalId":79490,"journal":{"name":"Geriatric nephrology and urology","volume":"4 1","pages":"173-181"},"PeriodicalIF":3.3,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73242525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Renal artery disease in the elderly. 老年人肾动脉疾病。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008366032420

W L Henrich

引用次数: 3

Peritoneal dialysis in older individuals. 老年人腹膜透析。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008374531974

J F Winchester

引用次数: 7

Diabetic nephropathy in patients with type II diabetes. 2型糖尿病患者的糖尿病肾病。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008378600115

J B Lewis

引用次数: 4

Practical Urodynamics is edited by Victor Nitti 《实用尿动力学》由Victor Nitti编辑

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/A:1008364316873

M. Hassouna

引用次数: 0

Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. 癸酸诺龙是治疗老年男性血液透析患者贫血的良好选择。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008306301255

A Gascón, J J Belvis, F Berisa, E Iglesias, V Estopiñán, J L Teruel

{"title":"Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.","authors":"A Gascón, J J Belvis, F Berisa, E Iglesias, V Estopiñán, J L Teruel","doi":"10.1023/a:1008306301255","DOIUrl":"https://doi.org/10.1023/a:1008306301255","url":null,"abstract":"Objective: To assess the efficiency of nandrolone decanoate (ND) in the control of anemia in elderly male patients on hemodialysis (HD), and to determine its influence on nutritional parameters.Design: A prospective 6-month study with randomization of patients on recombinant human erythropoietin (rHuEPO) therapy into two groups. Group A: rHuEPO was stopped before starting treatment with ND. Group E: rHuEPO was continued.Setting: Renal unit, tertiary-care center.Patients: 14 male patients in Group A and 19 patients, 12 males and 7 females, in Group E.Interventions: In Group A rHuEPO was stopped and ND 200 mg/I.M. weekly was given over six months.Results: The increase in hemoglobin and hematocrit levels was progressive with ND, and significant differences (p < 0.003) were evident after six months (9.6 +/- 1.0 vs 11.0 +/- 1.4 and 28.9 +/- 4.7 vs 33.0 +/- 4.7, respectively), which remained unmodified in Group E. Group A showed a significant increase in serum creatinine, total protein, transferrin and anthropometric parameters. These parameters remained stable and even presented a tendency to decrease in Group E. There was a significant rise in the concentration of triglycerides and a significant decrease in both HDL-cholesterol and apolipoprotein A-1 in Group A. However, lipoprotein (a) decreased significantly. No significant changes were detected in Group E.Conclusions: The use of ND would allow us an acceptable treatment of anemia as well as a better nutritional condition in elderly male patients on dialysis.","PeriodicalId":79490,"journal":{"name":"Geriatric nephrology and urology","volume":"9 2","pages":"67-72"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1023/a:1008306301255","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21380409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 48

Monitoring hypovolemia in healthy elderly subjects by measuring blood pressure response to Valsalva's maneuver. 通过测量血压对Valsalva手法的反应来监测健康老年人低血容量。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008331930548

D J van Kraaij, R W Jansen, W H Hoefnagels

{"title":"Monitoring hypovolemia in healthy elderly subjects by measuring blood pressure response to Valsalva's maneuver.","authors":"D J van Kraaij, R W Jansen, W H Hoefnagels","doi":"10.1023/a:1008331930548","DOIUrl":"https://doi.org/10.1023/a:1008331930548","url":null,"abstract":"Quantification of hypovolemia by physical examination has limited validity. We explored the use of non-invasive measurement of blood pressure (BP) response to Valsalva's maneuver in monitoring hypovolemia in nine healthy elderly volunteers, recruited from participants of the Nijmegen Annual Four-Days Marches. Heart rate (HR), systolic and diastolic BP, and mean arterial pressure (MAP) response (Finapres) to a Valsalva's maneuver as well as clinical and laboratory assessment of fluid balance were determined 5 minutes before, and 3, 5, and 48 hours after administration of 40 mg furosemide orally. Subjects' (4 males aged 74.2 +/- 3.0 years) weight was 66.1 +/- 9.7 kg, mean BP was 139 +/- 21 over 76 +/- 12 mm Hg. A maximum weight loss of -2.8 +/- 0.9% occurred 5 hours after furosemide administration. Systolic and diastolic BP, HR, clinical assessment scores, and serum creatinine and urea nitrogen did not change during the total study period. Significant changes occurred in Valsalva phase I to phase II systolic BP response (difference +14.2 +/- 11.3 mm Hg, ratio difference -0.09 +/- 0.07 after 5 hours, P < 0.01). Changes after 48 hours did not differ from baseline values. Finapres measurement of Valsalva BP response may be useful in monitoring hypovolemia in the elderly.","PeriodicalId":79490,"journal":{"name":"Geriatric nephrology and urology","volume":"9 2","pages":"73-9"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1023/a:1008331930548","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21380410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Geriatric urinary incontinence. 老年尿失禁。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008343422871

L T Sirls, T Rashid

引用次数: 25

Fluid and electroylyte balance in the elderly. 老年人体液和电解质平衡。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008319310938

L H Beck

引用次数: 3

Aging effects on drug disposition and effect. 年龄对药物处置和效果的影响。

Geriatric nephrology and urology Pub Date : 1999-01-01 DOI: 10.1023/a:1008333511884

D R Abernethy

引用次数: 14